Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2024 - 2025)
Insight Molecular Diagnostics (IMDX) posted Gains from Sales and Divestitures of $86000.0 for Q4 2025, up 405.88% sequentially from $17000.0 in Q4 2024, and up 405.88% YoY from $17000.0 in Q4 2024.
Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 2 years of Gains from Sales and Divestitures data on file, last reported at $86000.0 in Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 405.88% year-over-year to $86000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $86000.0 (up 405.88% YoY) and the FY2025 annual result came in at $86000.0, up 405.88% from the prior year.
- Gains from Sales and Divestitures grew to $86000.0 in Q4 2025 per IMDX's latest filing, from $17000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $86000.0 in Q4 2025, with the low at $4000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |